Brief: Aap Implantate Q2 EBITDA Loss Turns To Profit Of EUR 0.3 Million

aap Implantate AG

13/08/2021 06:44

Aug 13 (Reuters) - AAP IMPLANTATE AG  AAQ1k.DE :
    * DGAP-NEWS: AAP WITH POSITIVE EBITDA IN Q2 AND H1/2021 FOR
FIRST
TIME SINCE FOCUSING ON TRAUMA AND SIGNIFICANT SALES GROWTH OF
+74% (Q2) AND +37% (H1)
    * INCREASED SALES BY A SIGNIFICANT 74% AND 37% YEAR-ON-YEAR
IN Q2
AND FIRST SIX MONTHS OF FINANCIAL YEAR 2021 TO EUR 3.3 MILLION
(Q2/2020: EUR 1.9 MILLION) AND EUR 6.0 MILLION (H1/2020: EUR 4.4
MILLION)
    * EBITDA IN BOTH Q2 AND FIRST HALF OF 2021 OF EUR 0.3
MILLION
(Q2/2020: EUR -2.1 MILLION) AND EUR 0.1 MILLION (H1/2020: EUR
-4.3 MILLION)
    * IN TERMS OF SALES, MANAGEMENT BOARD ANTICIPATES AN
INCREASE IN
SECOND HALF OF 2021 COMPARED TO FIRST SIX MONTHS OF FINANCIAL
YEAR
    * EXPECTS SALES OF BETWEEN EUR 3.0 MILLION AND EUR 3.4
MILLION FOR
Q3
    * EXPECTS 2021 GROUP EBITDA TO BE AT UPPER END OF GUIDANCE
COMMUNICATED IN JANUARY

Source text for Eikon:  ID:nEQ20kfVza 
Further company coverage:  AAQ1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))